Bristol Myers second-quarter results beat expectations, helped by new drugs
By Michael Erman (Reuters) -Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth...
By Michael Erman (Reuters) -Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth...
By Suzanne McGee (Reuters) – The nine exchange-traded funds (ETFs) tied to the spot price...
(Reuters) -Newmont Corp beat Wall Street expectations for second-quarter profit on Wednesday, as the world’s...
By Arsheeya Bajwa (Reuters) -IBM beat analysts’ estimates for second-quarter revenue on Wednesday, riding on...
JOHANNESBURG (Reuters) – Visa prevented 80 million fraudulent transactions worth $40 billion globally last year...
(Reuters) – OpenAI has reassigned its artificial intelligence (AI) safety leader Aleksander Madry to a...
By Yuvraj Malik and Greg Bensinger (Reuters) -Alphabet beat second-quarter revenue estimates on Tuesday, driven...
By Granth Vanaik (Reuters) -Mattel beat Wall Street estimates for second-quarter profit on Tuesday, aided...
(Reuters) – A nationwide AT&T wireless outage in February that lasted for more than 12...
NEW YORK (Reuters) – Warren Buffett’s Berkshire Hathaway reduced its stake in BYD to below...